October 2019 | Solutions Insider

Catalent has expanded its European network through the addition of three new facilities, and the addition of significant expertise in oral drug development in Nottingham, UK, commercial spray drying manufacturing in Haverhill, UK, and commercial drug product manufacturing and packaging of oral dose and biologics in Anagni, Italy. Catalent has the industry’s leading European development and supply network with a total of 14 facilities. To learn more about how our expanded European capabilities can help your next project, join us on stand 121A82 from November 5 – 7, 2019.

Tastes of Germany Networking Reception

Come speak with a member of the Catalent team and enjoy some local German cuisine and beverages. Join great conversations at the Catalent stand 121A82 from 4:00 – 5:30 p.m. on November 5 and 6.

Join us during AAPS PharmSci360 November 3 - 6 in San Antonio, Texas. Attend one of our two partner presentations and join us for a lunch reception. Discover more about the latest technologies and best practices in drug development at our 10 scientific research posters.

Catalent Partner Presentations – November 6

Case Studies in Characterization and Formulation for your Oral Small Molecule Drugs - November 6, 10:30 - 11:30 a.m.

Mass Spectrometry Tools for Host Cell Protein (HCP) Analysis - November 6, 11:30 a.m. - 12:30 p.m.

Jake Leonard is a Pharmaceutical Chemist based at Catalent’s early-development center of excellence in San Diego. Jake focuses on developing formulations for molecules in pre-clinical stages to be administered intravenously, subcutaneously, intramuscularly, intradermally, dermally, via ophthalmic delivery or oral-solution. Discover what drives his passion for parenteral drug development. Access his works that include six peer-reviewed publications and scientific posters. Don’t miss his scientific research poster on November 4 during AAPS PharmSci360 - IV Infusion In-Use Compatibility of the Regulatory Hormone Melatonin at AAPS

BIOLOGICS

Webinar: “From Basics to Best Practices: Exploring Bioassays and Binding Assays” - Learn about the latest cell-based bioassays and binding assays, including applications, advancements, and outlook. A panel of four industry experts unravel the science and dive into some specific applications and address current issues and trends within bioassays and binding assays.

Poster: “Development of an Intensified Fed-Batch Process Utilizing N-1 Perfusion and ambr®15” - Utilization of perfusion during the N-1 stage allows for inoculation of the production bioreactor at a very high cell density. Learn how to combine N-1 perfusion with the ambr®15 bioreactor system to create a powerful tool for rapid development of a highly efficient cell culture process.

Article: “Best Practices for Studying Stability in Biologics” – It can be challenging to determine a clear stability strategy for Biologics. Catalent’s Rekha Patel and William Hatcher discuss steps companies need to take when setting up a current good manufacturing practice (CGMP)-compliant stability testing program for biologics.

CLINICAL SUPPLY / CLINICAL SERVICES

ORAL DRUG DELIVERY

Executive Summary: “Overcoming Manufacturing Challenges for Accelerated Drug Development” - Learn how to leverage drug development knowledge and build a strategy that maintains integrity, quality, and timeliness of the manufacturing process. Get expert insights on overcoming manufacturing challenges associated with expedited development and stability programs. (ID=1554)

Case study: “ZYDIS® ODT Unlocks a Patient Preference for Rapid Onset in the Treatment of Migraine” - It has been reported that surveys of migraine patients have revealed a preference for oral medications that leads to a resolution of their symptoms. This case study depicts how Biohaven Pharmaceuticals partnered with Catalent to formulate an orally disintegrating tablet (ODT) to create a convenient dosage form with shorter times for the treatment of acute migraine.

EBook: “The Formulation Complex - Unravelling the challenges and trends in formulation best practice” - Experts from BASF, Catalent and the University of Saskatchewan share their insight and experiences with developing lipid-based drug delivery systems. Download to get tips and advice on overcoming the most common formulation mishaps and why beginning with the end in mind is crucial.

CONSUMER HEALTH

Catalent is a great place to grow your career! Our teams are rapidly growing across all functions including Supply Chain, Manufacturing, Quality, Product Development, Human Resources & more. Apply today!